Management believes that the recurring EBITDA of FY19 will be higher than that assumed in the guidance previously disclosed to the market.
Following this earnings release, we expect to increase our target price by some 5-10%. This should trigger a change in recommendation from Sell to Reduce.
08 Nov 2019
9m 19: higher EBITDA guidance for FY19
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
9m 19: higher EBITDA guidance for FY19
Buzzi Spa (BZU:WBO) | 0 0 1.6% | Mkt Cap: 4,003m
- Published:
08 Nov 2019 -
Author:
Felix Brunotte -
Pages:
2
Management believes that the recurring EBITDA of FY19 will be higher than that assumed in the guidance previously disclosed to the market.
Following this earnings release, we expect to increase our target price by some 5-10%. This should trigger a change in recommendation from Sell to Reduce.